|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Commission | |||||
| Total net revenues | |||||
| Operating expenses: | |||||
| Revenue share | |||||
| Marketing and advertising | |||||
| Consumer care and enrollment | |||||
| Technology | |||||
| General and administrative | |||||
| Amortization of intangible assets | |||||
| Operating lease impairment charges | |||||
| Intangible asset impairment charges | |||||
| Restructuring and other related charges | |||||
| Indefinite and long-lived asset impairment charges | |||||
| Total operating expenses | |||||
| Income (loss) from operations | |||||
| Interest expense | |||||
| Gain on bargain purchase | |||||
| Loss on extinguishment of debt | |||||
| Other (income) expense, net | |||||
| Income (loss) before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net income (loss) | |||||
| Net income (loss) attributable to noncontrolling interests | |||||
| Net income (loss) attributable to GoHealth, Inc. | |||||
| Net loss per share (Note 8): | |||||
| Net income (loss) per share of Class A common stock—basic (in dollars per share) | |||||
| Net income (loss) per share of Class A common stock—diluted (in dollars per share) | |||||
| Weighted-average shares of Class A common stock outstanding—basic (in shares) | |||||
| Weighted-average shares of Class A common stock outstanding—diluted (in shares) | |||||
Loading...